Zhao B - Search Results

1

Evaluation of uveitis events in real-world patients receiving immune checkpoint inhibitors based on the FAERS database.

Fan Q, Chen H, Hu Y, Zhao B. Fan Q, et al. Among authors: zhao b. Cutan Ocul Toxicol. 2023 Jun;42(2):68-73. doi: 10.1080/15569527.2023.2208661. Epub 2023 May 11. Cutan Ocul Toxicol. 2023. PMID: 37130046

2

Cisplatin-induced cardiotoxicity with midrange ejection fraction: A case report and review of the literature.

Hu Y, Sun B, Zhao B, Mei D, Gu Q, Tian Z. Hu Y, et al. Among authors: zhao b. Medicine (Baltimore). 2018 Dec;97(52):e13807. doi: 10.1097/MD.0000000000013807. Medicine (Baltimore). 2018. PMID: 30593170 Free PMC article. Review.

3

Myocarditis following the use of different immune checkpoint inhibitor regimens: A real-world analysis of post-marketing surveillance data.

Fan Q, Hu Y, Yang C, Zhao B. Fan Q, et al. Among authors: zhao b. Int Immunopharmacol. 2019 Nov;76:105866. doi: 10.1016/j.intimp.2019.105866. Epub 2019 Sep 3. Int Immunopharmacol. 2019. PMID: 31491729

4

Colitis following the use of immune checkpoint inhibitors: A real-world analysis of spontaneous reports submitted to the FDA adverse event reporting system.

Hu Y, Gong J, Zhang L, Li X, Li X, Zhao B, Hai X. Hu Y, et al. Among authors: zhao b. Int Immunopharmacol. 2020 Jul;84:106601. doi: 10.1016/j.intimp.2020.106601. Epub 2020 May 16. Int Immunopharmacol. 2020. PMID: 32422528

5

Fournier Gangrene Associated with Sodium-Glucose Cotransporter-2 Inhibitors: A Pharmacovigilance Study with Data from the U.S. FDA Adverse Event Reporting System.

Hu Y, Bai Z, Tang Y, Liu R, Zhao B, Gong J, Mei D. Hu Y, et al. Among authors: zhao b. J Diabetes Res. 2020 Jul 8;2020:3695101. doi: 10.1155/2020/3695101. eCollection 2020. J Diabetes Res. 2020. PMID: 32695827 Free PMC article.

6

Renal adverse effects following the use of different immune checkpoint inhibitor regimens: A real-world pharmacoepidemiology study of post-marketing surveillance data.

Chen G, Qin Y, Fan QQ, Zhao B, Mei D, Li XM. Chen G, et al. Among authors: zhao b. Cancer Med. 2020 Sep;9(18):6576-6585. doi: 10.1002/cam4.3198. Epub 2020 Jul 27. Cancer Med. 2020. PMID: 32720449 Free PMC article.

7

Assessment of acute kidney injury related to small-molecule protein kinase inhibitors using the FDA adverse event reporting system.

Fan Q, Ma J, Zhang B, Li Q, Liu F, Zhao B. Fan Q, et al. Among authors: zhao b. Cancer Chemother Pharmacol. 2020 Nov;86(5):655-662. doi: 10.1007/s00280-020-04151-8. Epub 2020 Oct 1. Cancer Chemother Pharmacol. 2020. PMID: 33001273

8

Guillain-Barré syndrome in patients treated with immune checkpoint inhibitors.

Fan Q, Hu Y, Wang X, Zhao B. Fan Q, et al. Among authors: zhao b. J Neurol. 2021 Jun;268(6):2169-2174. doi: 10.1007/s00415-021-10404-0. Epub 2021 Jan 21. J Neurol. 2021. PMID: 33475824

9

Neuromuscular junction dysfunctions due to immune checkpoint inhibitors therapy: An analysis of FAERS data in the past 15 years.

Zhang P, Lao D, Chen H, Zhao B, Du Q, Zhai Q, Ye X, Yu B. Zhang P, et al. Among authors: zhao b. Front Immunol. 2022 Aug 22;13:778635. doi: 10.3389/fimmu.2022.778635. eCollection 2022. Front Immunol. 2022. PMID: 36081514 Free PMC article.

10

Risk monitoring and pharmacovigilance of programmed cell death protein 1 / programmed cell death 1 ligand 1 in cancer patients after solid organ transplantation.

Mei L, Li S, Fan Q, Zhao B, Mei D, Took R, Zhen J. Mei L, et al. Among authors: zhao b. Therapie. 2023 Jul-Aug;78(4):385-392. doi: 10.1016/j.therap.2022.10.001. Epub 2022 Oct 11. Therapie. 2023. PMID: 36481226

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,224 results

Search Page

Filters